Assessment of paraoxonase 1, xanthine oxidase and glutathione peroxidase activities, nitric oxide and thiol levels in women with polycystic ovary syndrome

Acta Obstetricia et Gynecologica Scandinavica

Volumn 91, Issue 3, 2012, Pages 326-330

  Baskol, Gulden ^a   Aygen, Ercan ^a   Erdem, Feray ^a   Caniklioǧlu, Ayşen ^a   Narin, Figen ^a   Şahin, Yilmaz ^a   Kaya, Tugba ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

human; nitric oxide; oxidative stress; paraoxonase 1 protein; polycystic ovary syndrome; Xanthine oxidase

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; GLUTATHIONE PEROXIDASE; NITRIC OXIDE; THIOL; XANTHINE OXIDASE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; OVARY POLYCYSTIC DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

EID: 84857536449     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/j.1600-0412.2011.01337.x     Document Type: Article

References (30)

1. Agarwal A, Gupta S, Sika S,. The role free radicals and antioxidants in reproduction. Curr Opin Obstet Gynecol. 2006; 18: 325-32. (Pubitemid 43864734)
2. Halliwell B,. Free radicals, antioxidants and human disease: curiosity, cause or consequence? Lancet. 1994; 344: 721-4.
3. Kelley EE, Hock T, Khoo NK, Richardson GR, Johnson KK, Powell PC, et al,. Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells. Free Radic Biol Med. 2006; 40: 952-9. (Pubitemid 43376004)
4. Baskol G, Baskol M, Kocer D,. Oxidative stress and antioxidant defenses in serum of patients with non-alcoholic steatohepatitis. Clin Biochem. 2007; 40: 776-80. (Pubitemid 46961959)
5. Sögüt S, Aydin E, Elyas H, Aksoy N, Ozyurt H, Totan Y, et al,. The activities of serum adenosine deaminase and xanthine oxidase enzymes in Behcet's disease. Clin Chim Acta. 2002; 325: 133-8. (Pubitemid 35279635)
6. Stichtenoth DO, Frölich JC,. Nitric oxide and inflammatory joint disease. Br J Rheumatol. 1998; 37: 246-57.
7. Michiels C, Rase M, Toussaint O, Remacle J,. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med. 1994; 17: 235-48.
8. Hu ML,. Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol. 1994; 233: 381-5.
9. Gan KN, Smolen A, Eckerson HW, La Du BN,. Purification of human serum paraoxonase/arylesterase: evidence for one esterase catalyzing both activities. Drug Metab Dispos. 1991; 19: 100-6.
10. Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M,. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice. Free Radic Biol Med. 2003; 34: 774-84. (Pubitemid 36288542)
11. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 82: 1193-7.
12. Prajde N, Weber G,. Malignant transformation-linked imbalance: decreased XO activity in hepatomas. FEBS Lett. 1975; 59: 245-9.
13. Bories PN, Bories C,. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem. 1995; 41: 904-7.
14. Eckerson EW, Romson J, Wyte C, La Du BN,. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet. 1983; 35: 214-27. (Pubitemid 13111118)
15. Paglia DE, Valentine WN,. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967; 70: 158-69.
16. Hu ML, Locie S, Cross CE, Motchnik P, Halliwell B,. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med. 1993; 121: 257-62. (Pubitemid 23073132)
17. Agarwal A, Gupta S, Sekhon L, Shah R,. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008; 10: 1375-403.
18. Sabuncu T, Vural H, Harma M, Harma M,. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease. Clin Biochem. 2001; 34: 407-13. (Pubitemid 32777851)
19. Duleba AJ, Fovouzi N, Karaca M, Pehlivan T, Kwintkiewicz J, Behman HR,. Proliferation of ovarian theca-interstitial cells is modulated by antioxidants and oxidative stress. Hum Reprod. 2004; 19: 1519-24. (Pubitemid 38997174)
20. Marsillach J, Checa MA, Pedro-Botet J, Carreras R, Joven J, Camps J,. Paraoxonase-1 in female infertility: a possible role against oxidative stress-induced inflammation. Fertil Steril. 2010; 94: 1132-4.
21. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, et al,. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic Biol Med. 1999; 26: 892-904. (Pubitemid 29198362)
22. Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN,. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its function: a possible peroxidative role for paraoxonase. J Clin Invest. 1998; 101: 1581-90. (Pubitemid 28198486)
23. Granger DN, Höllwarth ME, Parks DA,. Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol Scand Suppl. 1986; 548: 47-63. (Pubitemid 16090298)
24. McCord JM,. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985; 312: 159-63. (Pubitemid 15192863)
25. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J,. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39: 44-84. (Pubitemid 44566469)
26. Nacul AP, Andrade CD, Schwarz P, de Bittencourt PI Jr, Spritzer PM,. Nitric oxide and fibrinogen in polycystic ovary syndrome: associations with insulin resistance and obesity. Eur J Obstet Gynecol Reprod Biol. 2007; 133: 191-6. (Pubitemid 47069681)
27. Kaya C, Pabuçcu R, Koca C, OÄuz AK, Erkan AF, Korkmaz A, et al,. Relationship between interleukin-6 levels and ambulatory blood pressure in women with polycystic ovary syndrome. Fertil Steril. 2010; 94: 1437-43.
28. Vrbikova J, Tallova J, Bicikova M, Dyrakova K, Hill M, Starka L,. Plasma thiols and androgen levels in polycystic ovary syndrome. Clin Chem Lab Med. 2003; 41: 216-21. (Pubitemid 36336714)
29. Ciaccio M, Bellia C,. Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction. Curr Clin Pharmacol. 2010; 5: 30-6.
30. Bausenwein J, Serke H, Eberle K, Hirrlinger J, Jogschies P, Hmeidan FA, et al,. Elevated levels of oxidized low-density lipoprotein and of catalase activity in follicular fluid of obese women. Mol Hum Reprod. 2010; 16: 117-24.